Skip to main content
. 2013 May 28;31(23):2638–2646. doi: 10.1016/j.vaccine.2013.03.034

Fig. 3.

Fig. 3

Cost-effectiveness acceptability curves for the cohort model in scenarios analyses. Curves show results under routine infant vaccination (strategy A) of the effect of varying cost (per dose) of the vaccine, vaccine duration of protection (given in months following the priming and booster doses) and vaccine efficacy (VE).